{"id":"sailuotong-capsule","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of SaiLuoTong capsule is not fully understood, but it is believed to involve the activation of certain cellular pathways that promote blood flow and reduce inflammation. This may be achieved through the modulation of various molecular targets, including nitric oxide synthase and cyclooxygenase-2.","oneSentence":"SaiLuoTong capsule is a traditional Chinese medicine compound that works by improving blood circulation and reducing inflammation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:33:18.743Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"}]},"trialDetails":[{"nctId":"NCT03789760","phase":"PHASE3","title":"The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule","status":"COMPLETED","sponsor":"Shineway Pharmaceutical Co.,Ltd","startDate":"2019-04-10","conditions":"Vascular Dementia","enrollment":493},{"nctId":"NCT06228638","phase":"","title":"CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)","status":"UNKNOWN","sponsor":"Moleac Pte Ltd.","startDate":"2023-12-12","conditions":"Memory Impairment, Dementia, Vascular","enrollment":100},{"nctId":"NCT01978730","phase":"PHASE2","title":"The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule","status":"UNKNOWN","sponsor":"Shineway Pharmaceutical Co.,Ltd","startDate":"2011-12","conditions":"Vascular Dementia","enrollment":372}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["The effects of SaiLuoTong capsule on VaD"],"phase":"phase_3","status":"active","brandName":"SaiLuoTong capsule","genericName":"SaiLuoTong capsule","companyName":"Shineway Pharmaceutical Co.,Ltd","companyId":"shineway-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SaiLuoTong capsule is a small molecule neurokinin 1 receptor antagonist, classified as an antagonist. It is being studied for various conditions including memory impairment, dementia, vascular, and vascular dementia in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}